載入...
Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples
The antiplatelet agent clopidogrel, a prodrug that requires bioactivation through the cytochrome P450 2C19 (CYP2C19) enzyme, is commonly prescribed post‐percutaneous coronary intervention (PCI). Genetic variation in CYP2C19 contributes to individual variability in clopidogrel response, and can lead...
Na minha lista:
| 發表在: | Clin Transl Sci |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7070822/ https://ncbi.nlm.nih.gov/pubmed/31664775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12714 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|